Solriamfetol

Overview

Solriamfetol is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL4297620).

Patent & exclusivity (US)

Per the FDA Orange Book (6 approved US products), the latest listed US patent on Solriamfetol expires 30 Dec 2042 and exclusivity 17 Jun 2026. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

[(2R)-2-amino-3-phenylpropyl] carbamate

Canonical SMILES

C1=CC=C(C=C1)C[C@H](COC(=O)N)N

InChIKey

UCTRAOBQFUDCSR-SECBINFHSA-N